Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks 8-12-2025, 19:30

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK 18-06-2025, 15:00

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth 29-01-2025, 19:00